Windtree Therapeutics enters licensing deal with Lee’s Pharmaceutical and Zhaoke Pharmaceutical

Windtree Therapeutics is advancing multiple late-stage interventions for acute cardiovascular and pulmonary syndromes to support patients. Their goal is to develop unique therapies that significantly improve upon the treatment of severe, acute conditions such as heart failure and lung injury.